Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The Thoracic Cancer team at Stanford Cancer Center has deep experience in treating both early stage and complex cases of lung cancer. Our specialists will use state-of the-art diagnostics to rapidly assess your cancer. With new knowledge about the genetic makeup of tumor types, our team can provide a personalized treatment plan that matches your needs, and offers the lowest risk and greatest chance of cure.
Lung cancer and other thoracic cancers require expert care. At the Stanford Cancer Center, our multispecialty team of lung and thoracic cancer specialists has been at the forefront of performing lung-sparing surgeries, inventing radiation therapy techniques, and leading clinical trials resulting in new treatment paradigms.
Surgery may be the only required treatment, or is in some cases part of the treatment, for early stage lung cancers. Treatment for thoracic cancer may include one or more of the following:
What should you know about lung cancer? This infographic provides an overview of lung cancer and related statistics.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.